Braden Michael Leonard - Jun 11, 2024 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
10%+ Owner
Signature
Braden Michael Leonard
Stock symbol
ACRS
Transactions as of
Jun 11, 2024
Transactions value $
$1,781,897
Form type
4
Date filed
6/13/2024, 06:04 PM
Previous filing
May 16, 2024
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $1.08M +1M +10.64% $1.08 10.4M Jun 11, 2024 Holding of BML Investment Partners, L.P. F1
transaction ACRS Common Stock Purchase $94.1K +82.6K +0.79% $1.14 10.5M Jun 12, 2024 Holding of BML Investment Partners, L.P. F1, F2
transaction ACRS Common Stock Purchase $32.8K +28.6K +0.27% $1.14 10.5M Jun 13, 2024 Holding of BML Investment Partners, L.P. F1, F3
transaction ACRS Common Stock Purchase $575K +500K +4.76% $1.15 11M Jun 13, 2024 Holding of BML Investment Partners, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2 Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.14 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
F3 Represents shares purchased in multiple transactions resulting in a weighted average purchase price of $1.1445 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.